GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,430.00p
   
  • Change Today:
      14.50p
  • 52 Week High: 1,788.50
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,101.88m
  • Volume: 6,027,700
  • Market Cap: £58,657m
  • RiskGrade: 129

Latest ShareCast News

GSK's blood cancer treatment approved in Japan

By Benjamin Chiou

Date: Monday 19 May 2025

(Sharecast News) - GSK's Blenrep treatment has been approved by Japanese regulators when in combination for relapsed or refractory multiple myeloma, marking the second major approval of its kind for the drug, with more expected in 2025.

GSK ShareCast News

London close: Stocks finish choppy week in the b... 16-May-2025 ShareCast
GSK buys Boston's developmental liver disease dr... 14-May-2025 ShareCast
Pharma stocks slide as Trump threatens price cut... 12-May-2025 ShareCast
Sunday newspaper round-up: US-China, Aerospace, ... 11-May-2025 ShareCast
London close: FTSE snaps 16-day win streak ahead... 07-May-2025 ShareCast

GSK Regulatory News

Transaction in Own Shares 21-May-2025 07:00 RNS
Director/PDMR Shareholding 20-May-2025 15:30 RNS
Transaction in Own Shares 20-May-2025 07:00 RNS
Blenrep for 2L+ multiple myeloma approved in Japan 19-May-2025 07:00 RNS
Transaction in Own Shares 19-May-2025 07:00 RNS

GSK Newspaper Links

GSK and AstraZeneca take hit as Trump vows to ma... 12-May-2025 Times
GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent
GSK to cut hundreds of US jobs 01-Dec-2014 Telegraph
Ebola vaccine trials 'encouraging', says GSK 27-Nov-2014 Telegraph

GSK Tips & Analysis

Questor :GlaxoSmithKline 16-Apr-2014 Telegraph
Questor:GlaxoSmithKline 06-Oct-2011 Telegraph
Questor:GlaxoSmithKline 11-Aug-2011 Telegraph
Questor tip: GlaxoSmithKline 28-Jul-2011 Telegraph
Investment Column: GlaxoSmithKline 27-Jul-2011 The Independent

GSK News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,430.00p
Change Today 14.50p
% Change 1.02 %
52 Week High 1,788.50
52 Week Low 1,264.00
Volume 6,027,700
Shares Issued 4,101.88m
Market Cap £58,657m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
40.37% below the market average40.37% below the market average40.37% below the market average40.37% below the market average40.37% below the market average
10.64% below the sector average10.64% below the sector average10.64% below the sector average10.64% below the sector average10.64% below the sector average
Price Trend
12.35% above the market average12.35% above the market average12.35% above the market average12.35% above the market average12.35% above the market average
36.17% above the sector average36.17% above the sector average36.17% above the sector average36.17% above the sector average36.17% above the sector average
Income
74.08% above the market average74.08% above the market average74.08% above the market average74.08% above the market average74.08% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
38.49% below the market average38.49% below the market average38.49% below the market average38.49% below the market average38.49% below the market average
48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 14
Sell 3
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for 21-May-2025

Time Volume / Share Price
16:20 0 @ 1,433.50p
16:20 0 @ 1,433.50p
16:20 0 @ 1,433.50p
16:43 8,433 @ 1,430.03p
16:02 3 @ 1,428.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page